Empfehlungen zur Durchführung der MIBG- Szintigraphie bei Kindern

P. Olivier; P. Colarinha; J. Fettich; S. Fischer; K. Hahn; U. Porn; J. Frökier; F. Giammarile; I. Gordon; L. Kabasakal; M. Mann; M. Mitjavila; A. Piepsz; R. Sixt; J. van Velzen

doi:10.1055/s-2002-33279

Der Nuklearmediziner 2002; 25(2): 101-105
DOI: 10.1055/s-2002-33279

MIBG-Szintigraphie

Empfehlungen zur Durchführung der MIBG- Szintigraphie bei Kindern

Leitlinie übernommen vom Paediatric Committee der European Association of Nuclear Medicine (EANM)Guidelines for MIBG-scintigraphy in childrenP. Olivier¹ , P. Colarinha² , J. Fettich³ , S. Fischer⁴ , K. Hahn⁴ , U. Porn⁴ , J. Frökier⁵ , F. Giammarile⁶ , I. Gordon⁷ , L. Kabasakal⁸ , M. Mann⁹ , M. Mitjavila¹⁰ , A. Piepsz¹¹ , R. Sixt ¹² , J. van Velzen¹³

¹CHU Nancy, France
²Instituto Portugues de Oncologia, Lisbon, Portugal
³University Medical Centre Ljubljana, Slovenia
⁴Klinik fuer Nuklearmedizin, University of Munich, Germany
⁵Aarhus University Hospital - Skejby, Denmark
⁶Centre Léon Bérard, Lyon, France
⁷Great Ormond Street Hospital for Children, London, UK
⁸Cerraphasa Tipp Fakultesi, Nukleer Tipp Ana Bilim Dali, Aksaray, Turkey
⁹Red Cross Hospital Cape Town, South Africa
¹⁰Hospital Universitário de Getafe, Madrid, Spain
¹¹AZ VUB and CHU St Pierre, Brussels, Belgium
¹²Sahlgrenska University Hospital Oestra, Goeteborg, Sweden
¹³liaison person ARPES

Abstract

Zusammenfassung

Bei den vorliegenden Empfehlungen handelt es sich um die deutsche Übersetzung der vom Paediatric Committee der European Association of Nuclear Medicine (EANM) publizierten Guidelines.

Abstract

These “Empfehlungen” are the german translation of the Guidelines on MIBG-Scintigraphy in Children, which were published by the Paediatric Committee of the European Association of Nuclear Medicine.

Schlüsselwörter

MIBG-Szintigraphy - Leitlinie - Kinder

Key words

MIBG-scintigraphy - Guidelines - Children

Full Text

References

Literatur

1 Giammarile F, Boneu A , Edeline V, Lumbroso J, Siles S, Wioland M. Guide de realisation de la scintigraphie à la méta-iodobenzylguanidine (mIBG) en oncologie pédiatrique. Med Nucl. 2000; 24 35-41
2 Shapiro B, Copp J E, Sisson J C, Eyre P L, Wallis J, Beierwaltes W H . Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med. 1985; 26 576-585
3 Sisson J C, Shulkin B L. Nuclear medicine imaging of pheochromocytoma and neuroblastoma. Q J Nucl Med. 1999; 43 217-223
4 Leung A, Shapiro B, Hattner R, Kim E, de Kraker J, Ghazzar N, Hartmann O, Hoefnagel C A, Jamadar D A, Kloos R, Lizotte P, Lumbroso J, Rufini V, Shulkin B L, Sisson J C, Thein A, Troncone L. Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med. 1997; 38 1352-1357
5 Khafagi F A, Shapiro B, Fischer M, Sisson J C , Hutchinson R, Beierwaltes W H. Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine. Eur J Nucl Med. 1991; 18 191-198
6 Shulkin B L, Shapiro B. Current concepts on the diagnostic use of MIBG in children. J Nucl Med. 1998; 39 679-688
7 Wieland D M, Wu J, Brown L E, Mangner T J, Swanson D P, Beierwaltes W H . Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med. 1980; 21 349-353
8 Khafagi F A, Shapiro B, Gross M D. The adrenal gland. In: Maisey MN, Britton KE, Gilday DL (eds). Clinical Nuclear Medicine. Chapman & Hall, London 1989; 271-291
9 Kinnier-Wilson L M, Draper G J. Neuroblastoma, its natural history and prognosis: a study of 487 cases. Br Med J. 1974; 3 301-307
10 Young J L, Ries L G, Silverberg E, Horm J W, Miller R W. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer. 1986; 58 (Suppl 2) 598-602
11 Jacobs A, Delree M, Desprechins B, Otten J, Ferster A , Jonckheer M H, Mertens J, Ham H R, Piepsz A. Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience. Pediatr Radiol. 1990; 20 157-159
12 Gelfand M J. Meta-iodobenzylguanidine in children. Semin Nucl Med. 1993; 23 231-242
13 Lumbroso J D, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Leclere J G, Couanet D, Bayle C, Caillaud J M, Lemerle J. et al . Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans. Prog Clin Biol Res. 1988; 271 689-705
14 Parisi M T, Greene M K, Dykes T M, Moraldo T V, Sandler E D, Hattner R S. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma. Invest Radiol. 1992; 27 768-773
15 Moyes J, McCready V R, Fullbrook A. Neuroblastoma MIBG in its diagnosis and management. Springer 1989
16 Perel Y, Conway J, Kletzel M, Goldman J, Weiss S, Feyler A, Cohn S L. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma. J Pediatr Hematol Oncol. 1999; 21 13-18
17 Hoefnagel C A, De Kraker J, Valdes Olmos R A, Voute P A. [131I]MIBG as a first line treatment in advanced neuroblastoma. Q J Nucl Med. 1995; 39 (Suppl 1) 61-64
18 Lumbroso J, Hartmann O, Schlumberger M. Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. „Societe Francaise d'Oncologie Pediatrique” and Nuclear Medicine Co-investigators. J Nucl Biol Med. 1991; 35 220-223
19 Mairs R J. Neuroblastoma therapy using radiolabelled [131I]meta- iodobenzylguanidine ([131I]MIBG) in combination with other agents. Eur J Cancer. 1999; 35 1171-1173
20 Gordon I, Peters A M, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J. Skeletal assessment in neuroblastoma - the pitfalls of iodine-123- MIBG scans. J Nucl Med. 1990; 31 129-134
21 Solanki K K, Bomanji J, Moyes J, Mather S J, Trainer P J, Britton K E. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun. 1992; 13 513-521
22 Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I, Kolinska J, Gwidlet J. A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine. Eur J Nucl Med. 1990; 17 127-129
23 Stabin M G, Gelfand M J. Dosimetry of pediatric nuclear medicine procedures. Q J Nucl Med. 1998; 42 93-112
24 Pintelon H, Jonckheer M H, Piepsz A. Paediatric nuclear medicine procedures: routine sedation or management of anxiety. Nucl Med Commun. 1994; 15 664-666
25 Rufini V, Fisher G A, Shulkin B L, Sisson J C, Shapiro B. Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging. J Nucl Med. 1996; 37 1464-1468
26 Rufini V, Giordano A, Di Giuda D, Petrone A, Deb G, De Sio L, Donfrancesco A, Troncone L. [123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging. Q J Nucl Med. 1995; 4 25-28
27 Gelfand M J, Elgazzar A H, Kriss V M, Masters P R, Golsch G J. Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors. J Nucl Med. 1994; 35 1753-1757
28 Nakajo M, Shapiro B, Copp J , Kalff V, Gross M D, Sisson J C, Beierwaltes W H. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med. 1983; 24 672-682
29 Bonnin F, Lumbroso J, Tenenbaum F, Hartmann O, Parmentier C. Refining interpretation of MIBG scans in children. J Nucl Med. 1994; 35 803-810
30 Lumbroso J, Giammarile F, Hartmann O, Bonnin F, Parmentier C. Upper clavicular and cardiac meta-[123I]iodobenzylguanidine uptake in children. Q J Nucl Med. 1995; 39 17-20

Prof. Dr. med. K. Hahn

Klinik und Poliklinik für Nuklearmedizin

Ludwig-Maximilians-Universität München

Ziemssenstr. 1

80336 München

Phone: +49-89-61 60-24 42

Fax: +49-89-51 60-44 88

Email: hahn@nuk.med.uni-muenchen.de